Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (10): 625-626.
Previous Articles Next Articles
CHEN Chen1, WANG Yan2, FANG Wei1*
Received:2018-02-23
Revised:2018-11-27
Online:2018-10-20
Published:2018-11-27
CLC Number:
CHEN Chen, WANG Yan, FANG Wei. One Case of Lactic Acidosis Induced by Isoniazid Combined with Linezolid[J]. Chinese Journal of Pharmacovigilance, 2018, 15(10): 625-626.
| [1] 金惠铭. 病理生理学[M].7版.北京:人民卫生出版社,2008:54. [2] Kreisberg R A,Wood B C.Drug and Chemical-Induced Metabolic Acidosis[J].Clinics in Endocrinologyand Metabolism,1983,12(2):391-411. [3] Sridhar A,Sandeep Y,Krishnakishore P,et al.Fatal poisoning by isoniazid and rifampicin[J].Indian J Nephrol,2012,22(5):385-387. [4] 石富国,古明,马世平.一线主要抗结核药不良反应分布特点文献分析[J].中国药物警戒,2011,8(7):434-437. [5] Alvarez F G, Guntupalli K K.Isoniazid overdose: four case reports and review of the literature[J]. Intensive Care Medicine, 1995, 21(8):641-644. [6] Zuccarini N S,Yousuf T,Wozniczka D,et al.Lactic Acidosis Induced by Linezolid Mimics Symptoms of an Acute Intracranial Bleed: A Case Report and Literature Review[J].J Clin Med Res,2016,8(10):753-756. [7] Douros A, Grabowksi K, Stahlmann R.Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones[J]. Expert Opinion on Drug Metabolism & Toxicology,2015,11(12):1-11. [8] 李瑞珍,陈飞苑,陈伟兰.436例异烟肼致不良反应文献分析[J].中国药房,2007,18(8):620-622. [9] 白艳,王羽凝,李其,等.利奈唑胺不良反应的文献计量分析[J].中国临床药理学杂志,2015,31(24):2459-2461. [10] 钟蕾,张俊,焦立公.异烟肼风险识别及分析[J].中国药物警戒,2014,11(2):117-120. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
